Item 8.01 Other Events


                                       1

--------------------------------------------------------------------------------

On January 10, 2023, Acutus Medical, Inc. ("the Company") received a letter from The Nasdaq Stock Market LLC notifying the Company that it had regained compliance with Listing Rule 5450(a)(1), which requires that listed securities maintain a minimum closing bid price of at least $1.00 per share (the "Minimum Bid Requirement"). The Company regained compliance with the Minimum Bid Requirement based on the closing bid price of the Company's common stock on the Nasdaq Global Select Market between December 23, 2022 and January 9, 2023. The Company had previously been notified of its non-compliance with the Minimum Bid Requirement on November 2, 2022, as described in the Company's Current Report on Form 8-K filed on November 4, 2022.

Item 9.01. Financial Statements and Exhibits.



(d)Exhibits

   Exhibit
    Number                                            Description
104.0                Cover Page Interactive Data File (embedded within the Inline XBRL document)


                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses